20
Api Corporation Chiyoda-ku, Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Rosuvastatin calcium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2016-287 - Rev 00
This Chemical Type CEP, issued on January 10, 2019, remains in force until October 24, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2631 associated with this CEP further emphasizes